vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与美国合众银行（SMBC）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是美国合众银行的1.5倍（$75.5M vs $49.6M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 10.3%），美国合众银行自由现金流更多（$20.2M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 11.3%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
美国合众银行是一家总部位于明尼苏达州明尼阿波利斯、在特拉华州注册的美国跨国银行机构，截至2025年是美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的银行，旗下核心经营实体美国银行全国协会以U.S. Bank名义开展业务，提供银行、投资、抵押等相关金融服务。
PBYI vs SMBC — 直观对比
营收规模更大
PBYI
是对方的1.5倍
$49.6M
营收增速更快
PBYI
高出17.4%
10.3%
自由现金流更多
SMBC
多$5.8M
$14.4M
两年增速更快
PBYI
近两年复合增速
11.3%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $49.6M |
| 净利润 | — | $18.1M |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | 45.7% |
| 净利率 | — | 36.6% |
| 营收同比 | 27.7% | 10.3% |
| 净利润同比 | — | 23.9% |
| 每股收益（稀释后） | $0.26 | $1.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYISMBC
| Q4 25 | $75.5M | $49.6M | ||
| Q3 25 | $54.5M | $49.0M | ||
| Q2 25 | $52.4M | $47.6M | ||
| Q1 25 | $46.0M | $46.1M | ||
| Q4 24 | $59.1M | $45.0M | ||
| Q3 24 | $80.5M | $43.8M | ||
| Q2 24 | $47.1M | $42.9M | ||
| Q1 24 | $43.8M | $40.1M |
净利润PBYISMBC
| Q4 25 | — | $18.1M | ||
| Q3 25 | $8.8M | $15.7M | ||
| Q2 25 | $5.9M | $15.8M | ||
| Q1 25 | $3.0M | $15.7M | ||
| Q4 24 | — | $14.7M | ||
| Q3 24 | $20.3M | $12.5M | ||
| Q2 24 | $-4.5M | $13.5M | ||
| Q1 24 | $-4.8M | $11.3M |
毛利率PBYISMBC
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
营业利润率PBYISMBC
| Q4 25 | 22.7% | 45.7% | ||
| Q3 25 | 17.6% | 39.7% | ||
| Q2 25 | 12.7% | 40.2% | ||
| Q1 25 | 8.7% | 43.0% | ||
| Q4 24 | 22.6% | 42.7% | ||
| Q3 24 | 27.4% | 36.1% | ||
| Q2 24 | -4.6% | 39.6% | ||
| Q1 24 | -5.3% | 35.3% |
净利率PBYISMBC
| Q4 25 | — | 36.6% | ||
| Q3 25 | 16.2% | 31.9% | ||
| Q2 25 | 11.2% | 33.2% | ||
| Q1 25 | 6.5% | 34.0% | ||
| Q4 24 | — | 32.6% | ||
| Q3 24 | 25.2% | 28.4% | ||
| Q2 24 | -9.6% | 31.6% | ||
| Q1 24 | -11.0% | 28.2% |
每股收益（稀释后）PBYISMBC
| Q4 25 | $0.26 | $1.62 | ||
| Q3 25 | $0.17 | $1.38 | ||
| Q2 25 | $0.12 | $1.39 | ||
| Q1 25 | $0.06 | $1.39 | ||
| Q4 24 | $0.40 | $1.30 | ||
| Q3 24 | $0.41 | $1.10 | ||
| Q2 24 | $-0.09 | $1.20 | ||
| Q1 24 | $-0.10 | $0.99 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $134.1M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $567.4M |
| 总资产 | $216.3M | $5.1B |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYISMBC
| Q4 25 | $97.5M | $134.1M | ||
| Q3 25 | $94.4M | $124.1M | ||
| Q2 25 | $96.0M | $192.9M | ||
| Q1 25 | $93.2M | $226.9M | ||
| Q4 24 | $101.0M | $145.8M | ||
| Q3 24 | $96.7M | $75.3M | ||
| Q2 24 | $96.8M | $60.9M | ||
| Q1 24 | $107.2M | $168.3M |
总债务PBYISMBC
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYISMBC
| Q4 25 | $130.3M | $567.4M | ||
| Q3 25 | $115.3M | $560.2M | ||
| Q2 25 | $104.7M | $544.7M | ||
| Q1 25 | $97.1M | $528.8M | ||
| Q4 24 | $92.1M | $512.4M | ||
| Q3 24 | $71.1M | $505.6M | ||
| Q2 24 | $48.5M | $488.7M | ||
| Q1 24 | $51.0M | $479.6M |
总资产PBYISMBC
| Q4 25 | $216.3M | $5.1B | ||
| Q3 25 | $202.9M | $5.0B | ||
| Q2 25 | $194.9M | $5.0B | ||
| Q1 25 | $196.2M | $5.0B | ||
| Q4 24 | $213.3M | $4.9B | ||
| Q3 24 | $220.7M | $4.7B | ||
| Q2 24 | $205.0M | $4.6B | ||
| Q1 24 | $214.1M | $4.6B |
负债/权益比PBYISMBC
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $21.3M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $20.2M |
| 自由现金流率自由现金流/营收 | 19.1% | 40.6% |
| 资本支出强度资本支出/营收 | 0.0% | 2.2% |
| 现金转化率经营现金流/净利润 | — | 1.17× |
| 过去12个月自由现金流最近4个季度 | $41.7M | $133.6M |
8季度趋势，按日历期对齐
经营现金流PBYISMBC
| Q4 25 | $14.4M | $21.3M | ||
| Q3 25 | $9.7M | $16.3M | ||
| Q2 25 | $14.1M | $81.6M | ||
| Q1 25 | $3.6M | $24.1M | ||
| Q4 24 | $15.6M | $20.1M | ||
| Q3 24 | $11.0M | $10.0M | ||
| Q2 24 | $1.0M | $70.3M | ||
| Q1 24 | $11.2M | $23.9M |
自由现金流PBYISMBC
| Q4 25 | $14.4M | $20.2M | ||
| Q3 25 | $9.7M | $15.4M | ||
| Q2 25 | $14.1M | $75.3M | ||
| Q1 25 | $3.6M | $22.7M | ||
| Q4 24 | $15.6M | $18.2M | ||
| Q3 24 | $11.0M | $8.6M | ||
| Q2 24 | $1.0M | $61.2M | ||
| Q1 24 | — | $19.6M |
自由现金流率PBYISMBC
| Q4 25 | 19.1% | 40.6% | ||
| Q3 25 | 17.7% | 31.4% | ||
| Q2 25 | 26.8% | 158.1% | ||
| Q1 25 | 7.7% | 49.3% | ||
| Q4 24 | 26.4% | 40.3% | ||
| Q3 24 | 13.7% | 19.5% | ||
| Q2 24 | 2.1% | 142.8% | ||
| Q1 24 | — | 48.8% |
资本支出强度PBYISMBC
| Q4 25 | 0.0% | 2.2% | ||
| Q3 25 | 0.0% | 1.8% | ||
| Q2 25 | 0.0% | 13.2% | ||
| Q1 25 | 0.1% | 3.0% | ||
| Q4 24 | 0.0% | 4.4% | ||
| Q3 24 | 0.0% | 3.3% | ||
| Q2 24 | 0.0% | 21.1% | ||
| Q1 24 | 0.0% | 10.8% |
现金转化率PBYISMBC
| Q4 25 | — | 1.17× | ||
| Q3 25 | 1.10× | 1.04× | ||
| Q2 25 | 2.41× | 5.17× | ||
| Q1 25 | 1.21× | 1.54× | ||
| Q4 24 | — | 1.37× | ||
| Q3 24 | 0.54× | 0.80× | ||
| Q2 24 | — | 5.19× | ||
| Q1 24 | — | 2.11× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
